NanoVibronix, Inc. (NAOV)
USD 4.3
(10.97%)
USD 4.3
(10.97%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 2.73 Million USD | 25.61% |
| 2022 | 2.17 Million USD | 1142.86% |
| 2021 | 175 Thousand USD | 20.69% |
| 2020 | 145 Thousand USD | 19.83% |
| 2019 | 121 Thousand USD | -15.97% |
| 2018 | 144 Thousand USD | 89.47% |
| 2017 | 76 Thousand USD | 13.43% |
| 2016 | 67 Thousand USD | -5.63% |
| 2015 | 71 Thousand USD | 102.86% |
| 2014 | 35 Thousand USD | -46.15% |
| 2013 | 65 Thousand USD | 8.33% |
| 2012 | 60 Thousand USD | 0.0% |
| 2011 | - USD | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q2 | 2.43 Million USD | -6.07% |
| 2024 Q1 | 2.58 Million USD | -5.27% |
| 2023 Q2 | 3.11 Million USD | 40.71% |
| 2023 FY | 2.73 Million USD | 25.61% |
| 2023 Q1 | 2.21 Million USD | 1.75% |
| 2023 Q4 | 2.73 Million USD | -14.06% |
| 2023 Q3 | 3.17 Million USD | 2.09% |
| 2022 Q1 | 355 Thousand USD | 102.86% |
| 2022 Q3 | 1.55 Million USD | 67.35% |
| 2022 Q4 | 2.17 Million USD | 40.05% |
| 2022 FY | 2.17 Million USD | 1142.86% |
| 2022 Q2 | 928 Thousand USD | 161.41% |
| 2021 Q2 | 205 Thousand USD | 18.5% |
| 2021 Q1 | 173 Thousand USD | 19.31% |
| 2021 Q3 | 201 Thousand USD | -1.95% |
| 2021 FY | 175 Thousand USD | 20.69% |
| 2021 Q4 | 175 Thousand USD | -12.94% |
| 2020 Q4 | 145 Thousand USD | 33.03% |
| 2020 Q3 | 109 Thousand USD | -26.35% |
| 2020 FY | 145 Thousand USD | 19.83% |
| 2020 Q2 | 148 Thousand USD | 33.33% |
| 2020 Q1 | 111 Thousand USD | -8.26% |
| 2019 FY | 121 Thousand USD | -15.97% |
| 2019 Q1 | 141 Thousand USD | -2.08% |
| 2019 Q2 | 102 Thousand USD | -27.66% |
| 2019 Q3 | 104 Thousand USD | 1.96% |
| 2019 Q4 | 121 Thousand USD | 16.35% |
| 2018 Q2 | 78 Thousand USD | 0.0% |
| 2018 FY | 144 Thousand USD | 89.47% |
| 2018 Q3 | 134 Thousand USD | 71.79% |
| 2018 Q1 | 78 Thousand USD | 2.63% |
| 2018 Q4 | 144 Thousand USD | 7.46% |
| 2017 Q3 | 91 Thousand USD | 10.98% |
| 2017 Q2 | 82 Thousand USD | 36.67% |
| 2017 Q1 | 60 Thousand USD | -10.45% |
| 2017 FY | 76 Thousand USD | 13.43% |
| 2017 Q4 | 76 Thousand USD | -16.48% |
| 2016 FY | 67 Thousand USD | -5.63% |
| 2016 Q4 | 67 Thousand USD | 6.35% |
| 2016 Q3 | 63 Thousand USD | 6.78% |
| 2016 Q2 | 59 Thousand USD | -22.37% |
| 2016 Q1 | 76 Thousand USD | 7.04% |
| 2015 Q1 | 29 Thousand USD | -17.14% |
| 2015 Q3 | 74 Thousand USD | 39.62% |
| 2015 Q4 | 71 Thousand USD | -4.05% |
| 2015 FY | 71 Thousand USD | 102.86% |
| 2015 Q2 | 53 Thousand USD | 82.76% |
| 2014 Q3 | 34 Thousand USD | 0.0% |
| 2014 Q1 | 72 Thousand USD | 10.77% |
| 2014 Q4 | 35 Thousand USD | 2.94% |
| 2014 FY | 35 Thousand USD | -46.15% |
| 2013 Q1 | - USD | -100.0% |
| 2013 Q2 | 110 Thousand USD | 0.0% |
| 2013 Q3 | 72 Thousand USD | -34.55% |
| 2013 Q4 | 65 Thousand USD | -9.72% |
| 2013 FY | 65 Thousand USD | 8.33% |
| 2012 Q4 | 60 Thousand USD | 0.0% |
| 2012 FY | 60 Thousand USD | 0.0% |
| 2011 FY | - USD | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| AdaptHealth Corp. | 113.64 Million USD | 97.596% |
| Anika Therapeutics, Inc. | 46.38 Million USD | 94.11% |
| Accelerate Diagnostics, Inc. | 3.31 Million USD | 17.462% |
| BrainsWay Ltd. | 3.71 Million USD | 26.5% |
| Cerus Corporation | 39.86 Million USD | 93.147% |
| CVRx, Inc. | 10.98 Million USD | 75.125% |
| electroCore, Inc. | 2.16 Million USD | -26.481% |
| Heart Test Laboratories, Inc. | 629.17 Thousand USD | -334.217% |
| NeuroOne Medical Technologies Corporation | 1.72 Million USD | -58.222% |
| Helius Medical Technologies, Inc. | 457 Thousand USD | -497.812% |
| Orthofix Medical Inc. | 222.16 Million USD | 98.77% |
| Treace Medical Concepts, Inc. | 29.24 Million USD | 90.658% |
| iCAD, Inc. | 917 Thousand USD | -197.928% |
| IceCure Medical Ltd | 2.27 Million USD | -20.088% |
| 908 Devices Inc. | 14.93 Million USD | 81.711% |
| Inspira Technologies Oxy B.H.N. Ltd. | - USD | -Infinity% |
| Movano Inc. | 1.51 Million USD | -80.568% |
| MaxCyte, Inc. | 12.22 Million USD | 77.66% |
| Nexalin Technology, Inc. | 156.42 Thousand USD | -1646.58% |
| PAVmed Inc | 1.01 Million USD | -168.633% |
| Insulet Corporation | 402.6 Million USD | 99.321% |
| Quanterix Corporation | 22.36 Million USD | 87.784% |
| RxSight, Inc. | 17.42 Million USD | 84.318% |
| Sight Sciences, Inc. | 7.84 Million USD | 65.193% |
| Sintx Technologies, Inc. | 888 Thousand USD | -207.658% |
| Surmodics, Inc. | 14.83 Million USD | 81.589% |
| TriSalus Life Sciences, Inc. | 2.54 Million USD | -7.348% |
| Vivos Therapeutics, Inc. | 1.00 USD | -273199900.0% |
| Venus Concept Inc. | 28.67 Million USD | 90.473% |
| NeuroPace, Inc. | 11.21 Million USD | 75.638% |
| LENSAR, Inc. | 15.68 Million USD | 82.587% |
| Rapid Micro Biosystems, Inc. | 19.96 Million USD | 86.313% |
| SI-BONE, Inc. | 20.24 Million USD | 86.508% |
| TELA Bio, Inc. | 13.16 Million USD | 79.243% |
| Tivic Health Systems, Inc. | 756 Thousand USD | -261.376% |
| Lucid Diagnostics Inc. | 278 Thousand USD | -882.734% |
| LivaNova PLC | 147.88 Million USD | 98.153% |
| Bioventus Inc. | 91.33 Million USD | 97.009% |
| Envoy Medical, Inc. | 1.4 Million USD | -94.587% |
| Cytek Biosciences, Inc. | 60.87 Million USD | 95.512% |
| Spectral AI, Inc. | 230 Thousand USD | -1087.826% |
| Nano-X Imaging Ltd. | 2.35 Million USD | -15.959% |
| Aethlon Medical, Inc. | - USD | -Infinity% |
| Inogen, Inc. | 21.84 Million USD | 87.491% |
| OrthoPediatrics Corp. | 105.85 Million USD | 97.419% |
| Alphatec Holdings, Inc. | 136.84 Million USD | 98.004% |
| DIH Holding US, Inc. Warrants | - USD | -Infinity% |
| Apyx Medical Corporation | 9.92 Million USD | 72.468% |
| Cutera, Inc. | 72.1 Million USD | 96.211% |
| STRATA Skin Sciences, Inc. | 2.67 Million USD | -2.207% |
| BioSig Technologies, Inc. | -103 Thousand USD | 2752.427% |
| ClearPoint Neuro, Inc. | 7.91 Million USD | 65.466% |
| Integra LifeSciences Holdings Corporation | 389.6 Million USD | 99.299% |
| Axonics, Inc. | 79.94 Million USD | 96.582% |
| Outset Medical, Inc. | 49.21 Million USD | 94.449% |
| Monogram Orthopaedics, Inc. | 1.00 USD | -273199900.0% |
| IRIDEX Corporation | 9.9 Million USD | 72.421% |
| PROCEPT BioRobotics Corporation | 39.75 Million USD | 93.128% |
| IRadimed Corporation | 12.82 Million USD | 78.692% |
| INVO Bioscience, Inc. | 264.5 Thousand USD | -932.865% |
| Viemed Healthcare, Inc. | 4.6 Million USD | 40.664% |
| Varex Imaging Corporation | 277.5 Million USD | 99.015% |
| Quipt Home Medical Corp. | 18.32 Million USD | 85.092% |
| BIOLASE, Inc. | 11.43 Million USD | 76.104% |
| Beyond Air, Inc. | 2.12 Million USD | -28.444% |
| Pulmonx Corporation | 16.74 Million USD | 83.683% |
| Modular Medical, Inc. | - USD | -Infinity% |
| ReShape Lifesciences Inc. | 3.74 Million USD | 26.971% |
| FONAR Corporation | 2.71 Million USD | -0.61% |
| Semler Scientific, Inc. | 445 Thousand USD | -513.933% |
| InMode Ltd. | 45.09 Million USD | 93.942% |
| Bruker Corporation | 968.3 Million USD | 99.718% |
| Cytosorbents Corporation | 3.68 Million USD | 25.763% |
| DexCom, Inc. | 559.6 Million USD | 99.512% |
| Align Technology, Inc. | 296.9 Million USD | 99.08% |
| ZimVie Inc. | 79.6 Million USD | 96.568% |
| Nexalin Technology, Inc. | 156.42 Thousand USD | -1646.58% |
| DIH Holdings US, Inc. Class A Common Stock | - USD | -Infinity% |
| Tandem Diabetes Care, Inc. | 157.93 Million USD | 98.27% |
| Profound Medical Corp. | 6.95 Million USD | 60.709% |
| Vivani Medical, Inc. | - USD | -Infinity% |
| enVVeno Medical Corporation | - USD | -Infinity% |
| Inari Medical, Inc. | 42.9 Million USD | 93.632% |
| UFP Technologies, Inc. | 70.19 Million USD | 96.108% |
| QT Imaging Holdings, Inc. | - USD | -Infinity% |
| Nuwellis, Inc. | 1.99 Million USD | -36.805% |
| iRhythm Technologies, Inc. | 13.97 Million USD | 80.448% |
| InspireMD, Inc. | 2.1 Million USD | -29.725% |
| PAVmed Inc. | 1.01 Million USD | -168.633% |
| AxoGen, Inc. | 23.02 Million USD | 88.132% |
| Tactile Systems Technology, Inc. | 22.52 Million USD | 87.872% |
| Co-Diagnostics, Inc. | 1.66 Million USD | -64.111% |
| Tenon Medical, Inc. | 554 Thousand USD | -393.141% |
| Autonomix Medical, Inc. Common Stock | - USD | -Infinity% |
| Inspira Technologies Oxy B.H.N. Ltd. | - USD | -Infinity% |
| Sensus Healthcare, Inc. | 14.84 Million USD | 81.599% |
| Pacific Biosciences of California, Inc. | 56.67 Million USD | 95.18% |
| TransMedics Group, Inc. | 44.23 Million USD | 93.824% |
| ReWalk Robotics Ltd. | 5.65 Million USD | 51.672% |
| NeuroMetrix, Inc. | 1.55 Million USD | -75.192% |
| Hyperfine, Inc. | 6.58 Million USD | 58.493% |
| Establishment Labs Holdings Inc. | 79.93 Million USD | 96.582% |
| Biomerica, Inc. | 2.37 Million USD | -14.983% |
| Bone Biologics Corporation | -328.84 Thousand USD | 930.789% |
| AVITA Medical, Inc. | 3.12 Million USD | 12.476% |
| Bluejay Diagnostics, Inc. | - USD | -Infinity% |
| Silk Road Medical, Inc | 29.87 Million USD | 90.856% |